8-K
filed July 2, 2024, 7:59 PM ET
ticker VERA
CIK 0001831828
leadership
confidence high
sentiment neutral
materiality 0.55
Appoints David Johnson as COO effective July 1, 2024
Vera Therapeutics, Inc.
- David Johnson named COO; previously Chief Commercial Officer at Global Blood Therapeutics.
- Annual base salary of $500,000; eligible for bonus up to 40% of base salary.
- Granted option to purchase 160,000 shares at $36.29, vesting over 4 years.
- Severance: 9 months salary without change in control; 12 months with change in control.
- Johnson also receives up to $10,000 reimbursement for legal fees related to offer letter.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-24-174318
- form_type
- 8-K
- ticker
- VERA
- cik
- 0001831828
- company_name
- Vera Therapeutics, Inc.
- filed_at
- 2024-07-02T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:14.774421+00:00
- generated_at
- 2026-05-31T23:49:27.501772+00:00
- sec_items
- ["5.02", "9.01"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.55
- calibrated_materiality_score
- 0.55
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-24-174318
- json_url
- https://secwatch.observer/filing/0001193125-24-174318.json
- markdown_url
- https://secwatch.observer/filing/0001193125-24-174318.md
- text_url
- https://secwatch.observer/filing/0001193125-24-174318.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1831828/000119312524174318/0001193125-24-174318-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1831828/000119312524174318/d799103d8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
ALH
COO International Jan Vleugels to retire Sept 30; Bob Calver named successor; new VP IR
Alliance Laundry Holdings Inc.
June 2, 2026, 9:16 AM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On July 1, 2024, Vera Therapeutics, Inc. (the “ Company ”) announced the appointment of David Johnson as the Company’s Chief Operating Officer, effective July 1, 2024
Comparable filing
Mr. Jan Vleugals, Chief Operating Officer International of Alliance Laundry Holdings Inc. (the “Company”), provided notice of his decision to retire effective as of September 30, 2026
Filing page
SEC filing
ONCY
Oncolytics appoints Steve Glover to board, promotes John McAdory to COO
ONCOLYTICS BIOTECH INC
June 2, 2026, 9:02 AM ET
leadership
Items 5.02, 8.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On July 1, 2024, Vera Therapeutics, Inc. (the “ Company ”) announced the appointment of David Johnson as the Company’s Chief Operating Officer, effective July 1, 2024
Comparable filing
appointed John McAdory as Chief Operating Officer of the Company
Filing page
SEC filing
CRVL
CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026
CORVEL CORP
June 1, 2026, 5:05 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On July 1, 2024, Vera Therapeutics, Inc. (the “ Company ”) announced the appointment of David Johnson as the Company’s Chief Operating Officer, effective July 1, 2024
Comparable filing
In connection with the leadership transition, the Board appointed Sarah Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026.
Filing page
SEC filing
WTTR
Select Water Solutions COO Skarke moves to Chief Commercial Officer; no successor named
Select Water Solutions, Inc.
June 1, 2026, 5:00 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On July 1, 2024, Vera Therapeutics, Inc. (the “ Company ”) announced the appointment of David Johnson as the Company’s Chief Operating Officer, effective July 1, 2024
Comparable filing
Effective June 1, 2026, Michael C. Skarke transitioned from serving as the Executive Vice President and Chief Operating Officer of Select Water Solutions, Inc. (the “Company”) to serving as the Company’s Executive Vice President and Chief Commercial Officer,
Filing page
SEC filing
TTD
The Trade Desk appoints Nate Olmstead as CFO effective July 9, 2026; interim CFO Davis resumes CAO role
Trade Desk, Inc.
June 1, 2026, 4:35 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On July 1, 2024, Vera Therapeutics, Inc. (the “ Company ”) announced the appointment of David Johnson as the Company’s Chief Operating Officer, effective July 1, 2024
Comparable filing
On June 1, 2026, The Trade Desk, Inc. (the “Company”) announced the appointment of Nate Olmstead, age 54, as the Company’s chief financial officer.
Filing page
SEC filing
WST
West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair
WEST PHARMACEUTICAL SERVICES INC
June 1, 2026, 4:32 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On July 1, 2024, Vera Therapeutics, Inc. (the “ Company ”) announced the appointment of David Johnson as the Company’s Chief Operating Officer, effective July 1, 2024
Comparable filing
As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.
Filing page
SEC filing
LPX
LP Building Solutions announces CFO succession: Alan Haughie to retire; Aaron Howald named CFO effective Sept 1, 2026
LOUISIANA-PACIFIC CORP
June 1, 2026, 4:31 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On July 1, 2024, Vera Therapeutics, Inc. (the “ Company ”) announced the appointment of David Johnson as the Company’s Chief Operating Officer, effective July 1, 2024
Comparable filing
On May 27, 2026, Alan J.M. Haughie, Executive Vice President and Chief Financial Officer of Louisiana-Pacific Corporation (“LP”, the “Company”), notified the Board of Directors of LP (the “Board”) of his intention to retire from the role of Executive Vice President and Chief Financial Officer, effective September 1, 2026.
Filing page
SEC filing
PENG
Penguin Solutions CFO Nate Olmstead to step down; Aaron Johnson named interim CFO; reaffirms FY2026 guidance at high end
Penguin Solutions, Inc.
June 1, 2026, 4:17 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
On July 1, 2024, Vera Therapeutics, Inc. (the “ Company ”) announced the appointment of David Johnson as the Company’s Chief Operating Officer, effective July 1, 2024
Comparable filing
On May 31, 2026, the board of directors of the Company appointed Aaron Johnson, the Company’s Vice President, Finance and Accounting, as interim CFO and as the Company’s principal financial and accounting officer, succeeding Mr. Olmstead in these positions effective as of July 9, 2026, on an interim basis until the Company appoints a successor.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.